Emily Doyle
Plus aucun poste en cours
Profil
Emily Doyle served as Vice President-Global Human Resources at Globus Medical, Inc. from 2018 to 2019.
Prior to that, she was Head-Human Resources at AstraZeneca AB from 2015 to 2017.
She also held the position of Senior Vice President-Global Human Resources at Strongbridge Biopharma Plc.
Ms. Doyle received an undergraduate degree from Metropolitan State University of Denver.
Anciens postes connus de Emily Doyle
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBUS MEDICAL, INC. | Responsable des Ressources Humaines | 01/03/2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Responsable des Ressources Humaines | 01/01/2017 |
| STRONGBRIDGE BIOPHARMA | Responsable des Ressources Humaines | - |
Formation de Emily Doyle
| Metropolitan State University of Denver | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GLOBUS MEDICAL, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |